Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
B
|
Builders FirstSource Inc
F:B1F
|
US |
|
Hitachi Ltd
TSE:6501
|
JP |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
A
|
Allianz SE
F:ALV
|
DE |
|
B
|
Builders FirstSource Inc
SWB:B1F
|
US |
|
S
|
Shake Shack Inc
F:9SH
|
US |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
Ageas SA
MIL:1AGS
|
BE |
|
H
|
Hanjaya Mandala Sampoerna Tbk PT
XMUN:HSZ
|
ID |
|
L
|
Lumentum Holdings Inc
DUS:LU2
|
US |
|
C
|
Com7 PCL
SET:COM7
|
TH |
|
E
|
EverCommerce Inc
NASDAQ:EVCM
|
US |
|
A
|
Ageas SA
XMUN:FO4N
|
BE |
Intrinsic Value
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden
USD.
Compared with the current market price of 2.31 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
IKT looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with IKT’s past valuations and how the stock performed after similar periods.
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden USD.
Compared with the current market price of 2.31 USD, the stock appears hidden.